Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3646)
All Articles published online
|
Aug 15, 2014 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Uemura N, Kondo T. Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer. World J Gastrointest Pathophysiol 2014; 5(3): 322-334 [PMID: 25133032 DOI: 10.4291/wjgp.v5.i3.322] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v5/i3/322.htm |
| Number | Citing Articles |
| 1 |
Suun Sathornviriyapong, Akihisa Matsuda, Masao Miyashita, Satoshi Matsumoto, Nobuyuki Sakurazawa, Yoichi Kawano, Marina Yamada, Eiji Uchida. Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis. Annals of Surgical Oncology 2016; 23(11): 3632 doi: 10.1245/s10434-016-5298-9
|
| 2 |
L E Salnikova, D S Kolobkov. Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis. The Pharmacogenomics Journal 2016; 16(3): 249 doi: 10.1038/tpj.2015.46
|
| 3 |
Ju Guo, Kai Jin, Ting Tang, Hong-Mei Liu, Yu-An Xie. A new biomarker to enhance the radiosensitivity of hepatocellular cancer: miRNAs. Future Oncology 2022; 18(28): 3217 doi: 10.2217/fon-2022-0136
|
| 4 |
Guiming Chen, Jin Peng, Weiguo Zhu, Guangzhou Tao, Yaqi Song, Xilei Zhou, Wanwei Wang. Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy. Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0263-6
|
| 5 |
Jingzhen Shi, Yingjie Zhang, Jinzhi Wang, Jianbin Li, Zhenxiang Li. Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00995
|
| 6 |
Jun-Tao Tan, Yang Yang, Nai-Qun Mao, De-Sen Liu, Ding-Ming Huang, Hong Pan, Tong Xie, Qi Pan, Li Yang, Jian-Hong Zhong, Chuan-Tian Zuo. Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer. Diseases of the Esophagus 2016; doi: 10.1111/dote.12486
|
| 7 |
Nuo Li, Yang Yu, Baoming Wang. Downregulation of AAA-domain-containing protein 2 restrains cancer stem cell properties in esophageal squamous cell carcinoma via blockade of the Hedgehog signaling pathway. American Journal of Physiology-Cell Physiology 2020; 319(1): C93 doi: 10.1152/ajpcell.00133.2019
|
| 8 |
Hirsch Matani, Divya Sahu, Michael Paskewicz, Anastasia Gorbunova, Ashten N. Omstead, Rodney Wegner, Gene G. Finley, Blair A. Jobe, Ronan J. Kelly, Ali H. Zaidi, Ajay Goel. Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma. Biomarker Research 2022; 10(1) doi: 10.1186/s40364-022-00429-6
|
| 9 |
Cheng Tan, Xia Qian, Zhifeng Guan, Baixia Yang, Yangyang Ge, Feng Wang, Jing Cai. Potential biomarkers for esophageal cancer. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-2119-3
|
| 10 |
Ann-Kathrin Mueller, Kirsten Lindner, Richard Hummel, Jörg Haier, David I. Watson, Damian J. Hussey. MicroRNAs and Their Impact on Radiotherapy for Cancer. Radiation Research 2016; 185(6): 668 doi: 10.1667/RR14370.1
|
| 11 |
Tomohiro Murakami, Yoshiaki Shoji, Tomohiko Nishi, Shu‐Ching Chang, Ron D. Jachimowicz, Sojun Hoshimoto, Shigeshi Ono, Yosef Shiloh, Hiroya Takeuchi, Yuko Kitagawa, Dave S. B. Hoon, Matias A. Bustos. Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma. Molecular Oncology 2021; 15(4): 1069 doi: 10.1002/1878-0261.12929
|
| 12 |
Shunsuke Nakamura, Mitsuro Kanda, Masahiko Koike, Dai Shimizu, Shinichi Umeda, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka, Daisuke Kobayashi, Suguru Yamada, Kenji Omae, Yasuhiro Kodera. KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 2020; 27(7): 2559 doi: 10.1245/s10434-019-08189-8
|
| 13 |
Żaneta Kałuzińska, Damian Kołat, Andrzej K. Bednarek, Elżbieta Płuciennik. PLEK2, RRM2, GCSH: A Novel WWOX-Dependent Biomarker Triad of Glioblastoma at the Crossroads of Cytoskeleton Reorganization and Metabolism Alterations. Cancers 2021; 13(12): 2955 doi: 10.3390/cancers13122955
|
| 14 |
Maria Saigí, Marc Oliva, Luisa Aliste, Mariona Calvo, Gloria Hormigo, Òlbia Serra, Anna Boladeras, Leandre Farran, Javier Robles, Gloria Creus, Ma José Paúles, Joan B. Gornals, Eugenia de Lama, Josep Ma Borràs, Núria Sala, Maica Galán, Lanjing Zhang. Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre. PLOS ONE 2017; 12(9): e0184737 doi: 10.1371/journal.pone.0184737
|
| 15 |
YANAN JIANG, QIONG WU, XIAWEN YANG, JIMIN ZHAO, YUXI JIN, KE LI, YIHUI MA, XINHUAN CHEN, FANG TIAN, SONG ZHAO, JINGLONG XU, JING LU, XUESHAN YIN, KANGDONG LIU, ZIMING DONG. A method for establishing a patient-derived xenograft model to explore new therapeutic strategies for esophageal squamous cell carcinoma. Oncology Reports 2016; 35(2): 785 doi: 10.3892/or.2015.4459
|